Activation of CECR1 in M2-like TAMs promotes paracrine stimulation-mediated glial tumor progression

Changbin Zhu1,2, Dana Mustafa1, Ping-Pin Zheng1

  • 1Department of Pathology, Erasmus Medical Center, Rotterdam, The Netherlands.

Neuro-Oncology
|April 29, 2017
PubMed
Abstract

Insights

Cat Eye Syndrome Critical Region Protein 1 (CECR1) drives M2 macrophage polarization in gliomas, promoting tumor growth. This protein is highly expressed in high-grade gliomas and activates MAPK signaling, enhancing glioma cell proliferation and migration.

Area of Science:

  • Immunology
  • Neuro-oncology
  • Cancer Biology

Background:

  • Glioma-associated microglia/macrophages are predominantly M2-type, exhibiting immune suppressive and tumor-supportive functions.
  • Extracellular adenosine deaminase CECR1 (Cat Eye Syndrome Critical Region Protein 1) regulates macrophage maturation.
  • The role of CECR1 in regulating glioma-associated macrophage responses requires investigation.

Purpose of the Study:

  • To investigate the role of CECR1 in regulating the glioma-associated macrophage response.
  • To determine the expression patterns and functional impact of CECR1 in glioma microenvironments.

Main Methods:

  • Assessed CECR1 expression in human glioma samples.
  • Studied CECR1-mediated macrophage responses in vitro using primary monocytes and THP-1 cells.
  • Evaluated the effect of CECR1 manipulation on glioma cell line U87 response to conditioned macrophage media.

Main Results:

  • CECR1 expression was significantly elevated in high-grade gliomas and correlated with M2 phenotype markers in tumor-associated microglia/macrophages (TAMs).
  • In vitro, CECR1 expression was higher in M2-like macrophages exposed to glioma conditioned medium; CECR1 modulation affected M2-like differentiation.
  • CECR1 influenced U87 cell proliferation and migration via MAPK signaling, with expression correlating to Ki67 and MAPK pathway proteins in glioma tissues.

Conclusions:

  • CECR1 is a potent regulator of TAM polarization, consistently upregulated in M2-type TAMs within high-grade gliomas.
  • CECR1 in M2-like TAMs induces paracrine effects that activate MAPK signaling, thereby stimulating glioma cell proliferation and migration.

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
5.0K
The Tumor Microenvironment02:17

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
8.0K
Metastasis02:30

Metastasis

Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
6.7K
Tumor Progression02:07

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
7.6K